Literature DB >> 12402604

High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.

Ryo Yamamoto1, Masaaki Nakayama, Toshio Hasegawa, Numata Miwako, Hiroyasu Yamamoto, Keitaro Yokoyami, Masato Ikeda, Naohiko Kato, Hiroshi Hayakawa, Hajime Takahashi, Yasushi Otsuka, Yoshindo Kawaguchi, Tastuo Hosoya.   

Abstract

Increased peritoneal function has been suggested to be a risk factor for developing encapsulating peritoneal sclerosis (EPS); however, clinical evidence is scarce. The present study aimed to clarify the specific character of peritoneal function in patients who developed EPS after withdrawal from peritoneal dialysis (PD). We studied 12 patients who developed EPS after PD withdrawal [(EPS group) mean PD duration: 109 months; mean period of EPS development: 7.0 months after withdrawal] and 128 patients who did not develop EPS (non EPS group). All 140 patients were withdrawn from continuous ambulatory peritoneal dialysis (CAPD) and were observed for the following 24 months. Based on the records of the annual peritoneal equilibration tests (PETs), we analyzed (1) the patients' dialysate-to-plasma (D/P) creatinine at various durations on PD, and (2) the accumulative appearance incidence of high-transport (HT) state of peritoneal membrane. The mean D/P creatinine in EPS group was significantly higher than that in the non EPS group in the course of PD from the 6th to the 10th year. The accumulative incidence of HT was significantly higher in the EPS group than in the non EPS group, indicating early development of HT membrane in EPS group. Early development of increased D/P creatinine, classified as HT state, was observed during certain periods on PD in patients who developed EPS after PD withdrawal. That finding may indicate that HT state of peritoneal membrane is an early marker for EPS, and that the PET is useful to detect patients at high risk of EPS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402604

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  10 in total

1.  Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.

Authors:  Yasushi Otsuka; Masaaki Nakayama; Masato Ikeda; Ali M Sherif; Keitaro Yokoyama; Hiroyasu Yamamoto; Yoshindo Kawaguchi
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

2.  No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis.

Authors:  Guido Garosi; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-12       Impact factor: 2.370

3.  Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis.

Authors:  Ichiro Hirahara; Eiji Kusano; Yoshiyuki Morishita; Makoto Inoue; Tetsu Akimoto; Osamu Saito; Shigeaki Muto; Daisuke Nagata
Journal:  World J Nephrol       Date:  2016-03-06

4.  Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Authors:  Ryo Yamamoto; Yasushi Otsuka; Masaaki Nakayama; Yukio Maruyama; Naohiko Katoh; Masato Ikeda; Hiroyasu Yamamoto; Keitaro Yokoyama; Yoshindo Kawaguchi; Masato Matsushima
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

5.  Effluent markers related to epithelial mesenchymal transition with adjusted values for effluent cancer antigen 125 in peritoneal dialysis patients.

Authors:  Sonoo Mizuiri; Hiromichi Hemmi; Michitsune Arita; Reibin Tai; Yoshinari Hattori; Atsuhiko Muto; Yasunori Suzuki; Yasushi Ohashi; Ken Sakai; Atsushi Aikawa
Journal:  Int J Nephrol       Date:  2011-07-06

6.  Encapsulating peritoneal sclerosis following a peritoneal foreign body reaction to Dacron fibres-a case report.

Authors:  Margrét Árnadóttir; Jón Gunnlaugur Jónasson; Ólafur Skúli Indridason
Journal:  NDT Plus       Date:  2011-02-11

7.  Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

Authors:  Graham Woodrow; Stanley L Fan; Christopher Reid; Jeannette Denning; Andrew Neil Pyrah
Journal:  BMC Nephrol       Date:  2017-11-16       Impact factor: 2.388

8.  Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.

Authors:  Sudabeh Alatab; Iraj Najafi; Gholamreza Pourmand; Mostafa Hosseini; Soroosh Shekarchian
Journal:  Ren Fail       Date:  2016-10-24       Impact factor: 2.606

9.  Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients.

Authors:  Heng-Jung Hsu; Shih-Ying Yang; I-Wen Wu; Kuang-Hung Hsu; Chiao-Yin Sun; Chun-Yu Chen; Chin-Chan Lee
Journal:  Biomed Res Int       Date:  2018-11-13       Impact factor: 3.411

Review 10.  Risk factors for Encapsulating Peritoneal Sclerosis in patients undergoing peritoneal dialysis: A meta-analysis.

Authors:  Dashan Li; Yuanyuan Li; Hanxu Zeng; Yonggui Wu
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.